Merrimack Pharmaceuticals (MACK) News Today $12.78 -0.12 (-0.93%) (As of 11/28/2023 ET) Add Compare Share Share Today's Range$12.76▼$12.9250-Day Range$12.02▼$12.9052-Week Range$10.10▼$13.15Volume14,819 shsAverage Volume87,953 shsMarket Capitalization$183.01 millionP/E RatioN/ADividend YieldN/APrice TargetN/A HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMerrimack Pharmaceuticals Inc MACKmorningstar.com - November 10 at 11:39 PMMerrimack Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 2 at 7:27 PMOnconova Expands Leadership Team with Two Key Appointmentsstockhouse.com - October 24 at 8:53 AMThe Fight Against Pancreatic Cancer Just Gained a New Ally with $200M VC Firmtheglobeandmail.com - October 20 at 12:43 PMWestern Standard LLC Boosts Stake in Merrimack Pharmaceuticals Incfinance.yahoo.com - August 15 at 3:36 PMOnconova Therapeutics, Inc. (NASDAQ:ONTX) Q2 2023 Earnings Call Transcriptinsidermonkey.com - August 13 at 8:09 AMMerrimack Reports Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 3 at 8:17 PMPharming Group N.V.: Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Boardfinanznachrichten.de - July 18 at 1:19 AMPharming to nominate industry leader Dr. Richard Peters as new Chairman of the Boardfinance.yahoo.com - July 18 at 1:19 AMMerrimack Pharmaceuticals (NASDAQ:MACK) Stock Rating Lowered by StockNews.commarketbeat.com - July 7 at 10:15 PMMerrimack Pharmaceuticals (NASDAQ:MACK) Downgraded to "Sell" at StockNews.commarketbeat.com - June 23 at 10:15 PMMerrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is 22Nw LP's 6th Largest Positionmarketbeat.com - May 26 at 2:28 PMShort Interest in Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Increases By 6.7%marketbeat.com - May 2 at 3:48 AMMerrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Sees Large Drop in Short Interestmarketbeat.com - April 21 at 7:54 AMRetail investors account for 38% of Merrimack Pharmaceuticals, Inc.'s (NASDAQ:MACK) ownership, while hedge funds account for 33%finance.yahoo.com - April 19 at 7:33 AMGlobal Receptor Tyrosine Protein Kinase ERBB 3 Market Size Emerging Trends and Will Generate New Growth Opportunities Status 2030 By VMReportsmarketwatch.com - April 16 at 12:29 AMMerrimack Valley High Schoolusnews.com - April 15 at 7:26 PMWhy Merrimack Pharmaceuticals (MACK) Stock is Down in After-Hours Trading Todaythestreet.com - April 3 at 8:58 AMTrack Covid-19 in Merrimack County, New Hampshirenytimes.com - March 30 at 11:21 PMOncology Injection Drug Market Size and Forecast till 2031marketwatch.com - March 22 at 3:10 PMWhy Jounce Therapeutics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarketmsn.com - March 15 at 12:41 PMMerrimack Won a Title, but the N.C.A.A. Tournament Will Have to Waitnytimes.com - March 10 at 11:49 PMHistogen GAAP EPS of -$3.46, revenue of $3.77M misses by $0.35Mmsn.com - March 9 at 10:07 PMMerrimack Reports Full Year 2022 Financial Resultsfinance.yahoo.com - March 9 at 5:06 PMMerrimack, United States - Weather Forecasts | Maps | News - Yahoo Weatheryahoo.com - March 7 at 5:40 PMThe Global Liposomal Products Market is forecast to grow by $3,183.63 mn during 2022-2027, accelerating at a CAGR of 9.65% during the forecast perioduk.finance.yahoo.com - February 24 at 3:46 AMRadionetics Oncology Appoints Istvan Molnar, M.D. as Chief Medical Officerfinance.yahoo.com - February 22 at 10:25 AMGlobal HER2-Positive Breast Cancer Market to by In-depth Analysis of Revenue Forecast and Competitive Landscape 2030 By VMReportsmarketwatch.com - February 19 at 6:06 PMInsider Buying: Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Director Buys 4,156 Shares of Stockmarketbeat.com - January 9 at 6:31 PMShort Interest in Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Decreases By 23.1%marketbeat.com - January 2 at 12:09 PMTraders Buy High Volume of Merrimack Pharmaceuticals Put Options (NASDAQ:MACK)marketbeat.com - December 19 at 11:09 AMBullish Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) insiders filled their treasuries with US$574k worth of stock over last yearfinance.yahoo.com - December 13 at 3:46 PMMerrimack Pharmaceuticals (NASDAQ:MACK) Research Coverage Started at StockNews.commarketbeat.com - December 7 at 3:52 AMMerrimack Pharmaceuticals Extends Section 382 Net Operating Loss Rights Planfinance.yahoo.com - December 5 at 4:13 PMMerrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Short Interest Up 226.0% in Novembermarketbeat.com - November 28 at 11:09 PMStockNews.com Begins Coverage on Merrimack Pharmaceuticals (NASDAQ:MACK)marketbeat.com - November 22 at 5:12 AMBiotech Stock Roundup: MACK Up on Study Data, MRNA Offers Vaccine Update & Morefinance.yahoo.com - November 16 at 4:52 PMHedge funds investors control 44% of Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) and were rewarded last week after stock increased 228%finance.yahoo.com - November 10 at 6:47 PMMerrimack Soars On Promising Data From Ipsen's NAPOLI-3 Trialnasdaq.com - November 9 at 2:01 PMMerrimack stock rockets 200% after positive trial data on Onivyde pancreatic cancer treatmentfinance.yahoo.com - November 9 at 2:01 PMInvestors Purchase High Volume of Merrimack Pharmaceuticals Put Options (NASDAQ:MACK)marketbeat.com - November 9 at 10:51 AMWhy Is Merrimack Pharmaceuticals (MACK) Stock Up 220% Today?investorplace.com - November 9 at 10:24 AMMerrimack Pharmaceuticals Shares Soar Premarket on Ipsen Study Success >MACKmarketwatch.com - November 9 at 9:01 AMmarketbeat.com - November 8 at 10:17 AMMerrimack Reports Third Quarter 2022 Financial Resultsfinance.yahoo.com - November 3 at 4:54 PMReturn Of The Mack: A Deeply Misunderstood Near-Term Readoutseekingalpha.com - October 31 at 10:42 AMKnee Bursitis Treatment Market Analysis Research Report, Challenges, Scopes, Market Share, Revenue, and Forecasts 2022 to 2028marketwatch.com - October 26 at 12:17 PMMerrimack has 6 TDs in second half to run away from Wagnerusatoday.com - October 17 at 1:24 PMMerrimack Pharmaceuticals (NASDAQ: MACK)fool.com - September 2 at 10:45 PMCompanies Like Merrimack Pharmaceuticals (NASDAQ:MACK) Are In A Position To Invest In Growthfinance.yahoo.com - August 16 at 2:16 PM Get Merrimack Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MACK and its competitors with MarketBeat's FREE daily newsletter. Email Address MACK Media Mentions By Week MACK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MACK News Sentiment▼1.890.87▲Average Medical News Sentiment MACK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MACK Articles This Week▼10▲MACK Articles Average Week Get Merrimack Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MACK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SABS News ARQT News STOK News GOSS News DNTH News IPHA News BIVI News IMMP News IMRX News IVA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:MACK) was last updated on 11/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merrimack Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.